Published: February 3rd 2025 | Updated: March 4th 2025
Ocugen, Inc. receives European Medicines Agency ATMP designation for new gene therapy OCU400
Published: January 13th 2025 | Updated: February 5th 2025
Teva partners with Klinge Biopharma, Lotus Pharmaceutical for commercialisation of Formycon’s FYB203 (biosimilar aflibercept)
Published: January 31st 2024 | Updated: May 9th 2024
How biosimilars expand treatment options for patients with retinal disease
Published: March 7th 2025 | Updated: May 23rd 2025
Heidelberg Engineering announces two-day International SPECTRALIS Symposium
Published: May 19th 2025 | Updated: May 23rd 2025
Topline results from investigational nAMD drop SYL1801 (Sylentis)
Published: May 8th 2025 | Updated: May 23rd 2025
Teprotumumab (Tepezza, Amgen) receives marketing authorisation from MHRA